NCT00034515View on ClinicalTrials.gov

A Study in Adult and Pediatric Patients With Cystic Fibrosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Cystic Fibrosis
Interventions
DRUG

denufosol tetrasodium (INS37217) Inhalation Solution

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00034515 - A Study in Adult and Pediatric Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter